Your browser doesn't support javascript.
loading
PTEN expression and mutations in TSC1, TSC2 and MTOR are associated with response to rapalogs in patients with renal cell carcinoma.
Roldan-Romero, Juan M; Beuselinck, Benoit; Santos, María; Rodriguez-Moreno, Juan F; Lanillos, Javier; Calsina, Bruna; Gutierrez, Ana; Tang, Karin; Lainez, Nuria; Puente, Javier; Castellano, Daniel; Esteban, Emilio; Climent, Miguel A; Arranz, Jose A; Albersen, Maarten; Oudard, Stephane; Couchy, Gabrielle; Caleiras, Eduardo; Montero-Conde, Cristina; Cascón, Alberto; Robledo, Mercedes; Rodríguez-Antona, Cristina; García-Donas, Jesús.
Afiliação
  • Roldan-Romero JM; Hereditary Endocrine Cancer Group, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Beuselinck B; Laboratory of Experimental Oncology, Department of Oncology, University of Leuven, Leuven, Belgium.
  • Santos M; Hereditary Endocrine Cancer Group, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Rodriguez-Moreno JF; Genitourinary and Gynecological Cancer Unit, HM Hospitales - Centro Integral Oncológico HM Clara Campal, Madrid, Spain.
  • Lanillos J; Hereditary Endocrine Cancer Group, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Calsina B; Hereditary Endocrine Cancer Group, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Gutierrez A; Hospital HM Puerta del Sur, Móstoles, Spain.
  • Tang K; Hospital Universitario de Móstoles, Móstoles, Spain.
  • Lainez N; Complejo Hospitalario de Navarra, Pamplona, Spain.
  • Puente J; Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), CIBERONC, Madrid, Spain.
  • Castellano D; Hospital Universitario Doce de Octubre, Madrid, Spain.
  • Esteban E; Hospital Central de Asturias, Oviedo, Spain.
  • Climent MA; Fundación Instituto Valenciano de Oncologia, Valencia, Spain.
  • Arranz JA; Hospital General Universitario Gregorio Marañón, Madrid, Spain.
  • Albersen M; Department of Urology, University Hospitals Leuven, Leuven, Belgium.
  • Oudard S; Department of Medical Oncology, Hôpital Européen Georges-Pompidou, Paris, France.
  • Couchy G; Inserm UMR 1162, Université Paris-Descartes, Paris, France.
  • Caleiras E; Histopathology Core Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Montero-Conde C; Hereditary Endocrine Cancer Group, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Cascón A; Hereditary Endocrine Cancer Group, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Robledo M; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain.
  • Rodríguez-Antona C; Hereditary Endocrine Cancer Group, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • García-Donas J; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain.
Int J Cancer ; 146(5): 1435-1444, 2020 03 01.
Article em En | MEDLINE | ID: mdl-31335987
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Biomarcadores Tumorais / Resistencia a Medicamentos Antineoplásicos / Neoplasias Renais / Antineoplásicos Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged80 Idioma: En Revista: Int J Cancer Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Espanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Biomarcadores Tumorais / Resistencia a Medicamentos Antineoplásicos / Neoplasias Renais / Antineoplásicos Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged80 Idioma: En Revista: Int J Cancer Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Espanha